---
name: Rapid Novor Inc.
slug: rapidnovor
site: cro
website_domain: rapidnovor.com
summary: Rapid Novor provides antibody discovery, sequencing, and characterization services powered by mass spectrometry, including de novo sequencing, HDX-MS epitope mapping, and surface plasmon resonance analysis.
tagline: Mass spectrometry-powered antibody discovery and characterization CRO
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-10-13T07:03:22.329Z
services_count: 4
modalities_count: 1
indications_count: 0
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Rapid Novor Inc.

Mass spectrometry-powered antibody discovery and characterization CRO

Listed on cro.directory.

## Summary

Rapid Novor provides antibody discovery, sequencing, and characterization services powered by mass spectrometry, including de novo sequencing, HDX-MS epitope mapping, and surface plasmon resonance analysis.

## Services

- Protein Engineering
- Discovery Research
- Target Identification & Validation
- Proteomics Services

## Modalities

- Biologics (Monoclonal Antibodies)

## Long description

Rapid Novor is a contract research organization specializing in antibody protein characterization and discovery services. The company offers a comprehensive suite of capabilities including:

**Antibody Discovery & Development**
- Nanobody discovery
- Human antibody discovery
- Anti-idiotype antibody discovery
- Custom antibody development
- Recombinant antibody expression

**Protein Sequencing & Analysis**
- De novo protein sequencing
- Antibody sequencing
- Polyclonal antibody sequencing
- Peptide mapping and analysis
- Intact mass analysis of antibodies
- Glycan analysis
- Post-translational modification (PTM) analysis
- Disulfide bond analysis
- Drug antibody ratio (DAR) analysis

**Functional Characterization**
- HDX-MS epitope mapping
- Surface plasmon resonance (SPR) for antibody-antigen interaction analysis

**Applications**
Rapid Novor supports clients across multiple therapeutic areas and development stages, including antibody engineering, IP protection, hybridoma loss prevention, in vitro diagnostics, biologics drug discovery, target validation, gene and cell therapy development, cell line development, biosimilar development, and validation of AI-designed antibodies. The company also serves veterinary medicine and research applications.

## Related companies

- [AvantGen, Inc.](/companies/avantgen) (Protein Engineering, Discovery Research) — [Compare](/compare/avantgen/rapidnovor)
- [Qoolabs, Inc](/companies/qoolabs) (Protein Engineering, Biologics (Monoclonal Antibodies)) — [Compare](/compare/qoolabs/rapidnovor)
- [Accelagen, Inc.](/companies/accelagen) (Protein Engineering, Biologics (Monoclonal Antibodies)) — [Compare](/compare/accelagen/rapidnovor)
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) (Protein Engineering, Discovery Research) — [Compare](/compare/aurigeneservices/rapidnovor)
- [TRiCBIO](/companies/tricbio) (Discovery Research, Target Identification & Validation) — [Compare](/compare/rapidnovor/tricbio)
- [Proone Labs](/companies/proonelabs) (Protein Engineering, Discovery Research) — [Compare](/compare/proonelabs/rapidnovor)
- [Axxam](/companies/axxam) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axxam/rapidnovor)
- [IPM Biotech](/companies/ipmbiotech) (Protein Engineering, Discovery Research) — [Compare](/compare/ipmbiotech/rapidnovor)

_Profile last updated: 2026-10-13T07:03:22.329Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.